Defective base excision repair in the response to DNA damaging agents in triple negative breast cancerKevin J. Lee, Natalie R. Gassman, Cortt G. Piett et al.|PLoS ONE|2019Cited by 32
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancerRebecca M. Borneman, Luciana Madeira da Silva, Elaine Gavin et al.|Journal of Ovarian Research|2022Cited by 20
Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-CateninKevin J. Lee, Gary A. Piazza, Wen‐Chi Chang et al.|Cancer Prevention Research|2021Cited by 19
Defective base excision repair in the response to DNA damaging agents in triple negative breast cancerKevin J. Lee, Natalie R. Gassman, Cortt G. Piett et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 11
Abstract A30: Novel non-COX inhibitory sulindac derivative with PDE10 inhibitory activity reduces incidence and multiplicity of colorectal adenomas in the APC+/min-FCCC mouse modelKevin J. Lee, Wen‐Chi Chang, Xi Chen et al.|Cancer Research|2017Cited by 1